Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Retained Earnings (2016 - 2025)

Adma Biologics (ADMA) has disclosed Retained Earnings for 14 consecutive years, with -$161.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings rose 47.61% year-over-year to -$161.7 million, compared with a TTM value of -$161.7 million through Dec 2025, up 47.61%, and an annual FY2025 reading of -$161.7 million, up 47.61% over the prior year.
  • Retained Earnings was -$161.7 million for Q4 2025 at Adma Biologics, up from -$211.0 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$161.7 million in Q4 2025 and bottomed at -$506.3 million in Q4 2023.
  • Average Retained Earnings over 5 years is -$396.1 million, with a median of -$428.8 million recorded in 2022.
  • The sharpest move saw Retained Earnings decreased 26.37% in 2021, then skyrocketed 49.81% in 2025.
  • Year by year, Retained Earnings stood at -$412.1 million in 2021, then fell by 15.99% to -$478.0 million in 2022, then fell by 5.91% to -$506.3 million in 2023, then soared by 39.05% to -$308.6 million in 2024, then surged by 47.61% to -$161.7 million in 2025.
  • Business Quant data shows Retained Earnings for ADMA at -$161.7 million in Q4 2025, -$211.0 million in Q3 2025, and -$247.5 million in Q2 2025.